Lyrica®利痛抑®

有效紓緩神經痛感及改善廣泛性焦慮症1

多項國際指引認可第一線藥物之一 2-5

  • 參考資料PM-COR-24-102903 NOV 2024

    1. Lyrica® (pregabalin) Prescribing Information. Version August 2022.
    2. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.
    3. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry. 2008;9(4):248-312.
    4. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173.
    5. National Institute for Health and Care Excellence. Neuropathic pain in adults: Pharmacological management in non-specialist settings. Available at: https://www.nice.org.uk/guidance/cg173. Accessed on Sep 2024.
    6. Dworkin RH, Corbin AE, Young JP, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60(8):1274-1283.

相關疾病